ArticleCancer gene therapy2013
Bicalutamide-activated oncolytic adenovirus for the adjuvant therapy of high-risk prostate cancer.
T J Johnson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleCancer gene therapy2013
T J Johnson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.